Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) will support basic, translational, and clinical research to improve the understanding of the effector or immunoregulatory potentials of NK cells for HIV prevention, control and/or eradication.

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • AIDS Deadline: July 28, 2020‚Äč

RFA-AI-20-16 Expiration Date July 29, 2020

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

July 28, 2020